• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Magnetic Dressing Improves Diabetic Wound Healing

      Magnetic Dressing Improves Diabetic Wound Healing

      Eko’s Newest CORE 500 Stethoscope: A Review

      Eko’s Newest CORE 500 Stethoscope: A Review

      Microfluidic System Incorporates Eight Organ Tissues for Drug Testing

      Microfluidic System Incorporates Eight Organ Tissues for Drug Testing

      Suction Cup Delivers Drugs Through Cheek

      Suction Cup Delivers Drugs Through Cheek

    • Radiology
      Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

      Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Imaging Technique Reveals Living Brain Tissue in its Complexity

    • Cardiology
      Eko’s Newest CORE 500 Stethoscope: A Review

      Eko’s Newest CORE 500 Stethoscope: A Review

      Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

      Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      3D Printed Heart Muscle Beats

      3D Printed Heart Muscle Beats

    • Surgery
      Magnetic Dressing Improves Diabetic Wound Healing

      Magnetic Dressing Improves Diabetic Wound Healing

      Sensor Monitors Transplanted Organs for Signs of Rejection

      Sensor Monitors Transplanted Organs for Signs of Rejection

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

    • Nanomedicine
      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

    • Military Medicine
      Wearable Can Take Multiple Sweat Samples

      Wearable Can Take Multiple Sweat Samples

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

    • Rehab
      Stretchable E-Skin for Robotic Prostheses

      Stretchable E-Skin for Robotic Prostheses

      Glasses Provide Audible Prompts for Blind Wearers

      Glasses Provide Audible Prompts for Blind Wearers

      A Wearable to Manage Parkinson’s Motor Symptoms: Interview with Lucy Jung, CEO at Charco Neurotech

      A Wearable to Manage Parkinson’s Motor Symptoms: Interview with Lucy Jung, CEO at Charco Neurotech

      Robotic Ankle Helps with Postural Control in Amputees

      Robotic Ankle Helps with Postural Control in Amputees

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Non-Hodgkin Lymphoma Treatment Market 2021 | Top Manufacturers Overview, Insights, Global Industry Research, Size, Analysis, Revenue and Growth Forecast to 2026

May 11th, 2021 Fortune Business Insights Releases

Non Hodgkin Lymphoma Treatment Market | 2021 Size, Growth, Share, Cap, Regional Analysis With Global Industry Forecast To 2027. The global non-Hodgkin lymphoma treatment market size is projected to reach USD 12.57 billion by the end of 2026. The increasing number of regulatory approvals will aid the growth of the market in the coming years. According to a report published by Fortune Business Insights, titled “Non-Hodgkin Lymphoma Treatment Market Size, Share & Industry Analysis, By Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, and Others), By Disease Type (B-cell Lymphoma, and T-cell Lymphoma), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others), and Regional Forecast, 2019-2026,” the market was worth USD 6.60 billion in 2018 and will exhibit a CAGR of 8.4% during the forecast period.

Key Players Operating in The Non-Hodgkin Lymphoma Treatment Market Include:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

  • Takeda Pharmaceutical Company Limited
  • AstraZeneca
  • Bayer AG
  • Novartis AG
  • Kite Pharma, Inc. / Gilead Sciences, Inc.
  • Spectrum Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Bristol Myers Squibb Company
  • Janssen Pharmaceuticals, Inc.
  • Genentech, Inc. (F. Hoffmann-La Roche Ltd)
  • CELGENE CORPORATION (Bristol Myers Squibb Company)
  • Merck & Co., Inc.
  • Kyowa Kirin Co., Ltd.
  • AbbVie Inc.
  • Sanofi
  • Others

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/non-hodgkin-lymphoma-treatment-market-102642

Global Non-Hodgkin Lymphoma Treatment Market Highlights:

The Non-Hodgkin Lymphoma Treatment Market report offers an in-depth analysis of the Non-Hodgkin Lymphoma Treatment industry and the demand drivers by highlighting information on several aspects of the market. Prudent Markets addresses all these aspects and provides the latest scoop and detailed eye-opening study on all major & emerging business segments. In addition to this, the report sheds light on the industry developments by key players, which are contributing to the expansion of this industry. The development scope, feasibility study, Non-Hodgkin Lymphoma Treatment market concentration, and maturity analysis is elaborated in this report.

Information given in the research report pertains to different technological advancements introduced in recent years, which allows for a meticulous analysis of the industry and offers a more comprehensive understanding to the readers.

Increasing Number of Regulatory Approvals Will Aid Growth

The report encompasses several factors that have contributed to the growth of the market in recent years. Among all factors, the increasing number of regulatory approvals has made a huge impact on the growth of the overall market. In October 2017, AstraZeneca announced that it has received approval from the US Food and Drug Administration (FDA) for its latest treatment option for non-Hodgkin lymphoma. The company announced that ‘Calquence’ was cleared for use in treatment of patients suffering from the disease. The company looks to build on its previous steps taken to establish a stronghold in the market. This product will not just help the company grow, but will also have a positive impact on the growth of the market in the forthcoming years.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/non-hodgkin-lymphoma-treatment-market-102642

Regional Analysis:

  • North America (the USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

This report focuses on Non-Hodgkin Lymphoma Treatment Global Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2026, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.

North America to Emerge Dominant; Increasing Adoption of Automated Products Will Aid Growth

The report analyzes the ongoing non-Hodgkin lymphoma treatment market trends across North America, Latin America, Asia Pacific, the Middle East and Africa, and Europe. Among these regions, the market in North America held the largest market share in 2018. The efforts put in by large scale companies towards the development of efficient treatment options associated with the disease will aid the growth of the regional market. Moreover, the high prevalence of the disease in this region will also contribute to market growth. As of 2018, the market in North America was worth USD 3.16 billion and this value is projected to increase further in the coming years. The market in Europe and Asia Pacific will also witness considerable growth in the coming years, driven by the improving healthcare reimbursement policies in several countries across this region.

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market. Furthermore, the report offers a detailed analysis and information as per Non Hodgkin Lymphoma Treatment Market Growth Analysis by manufacturers, market segments helping our readers to get a comprehensive overview of the global market. Several players are planning to focus on developing cost-effective products or services, aiming to maintain a strong foothold in the market.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/non-hodgkin-lymphoma-treatment-market-102642

Table Of Content:

1 Non Hodgkin Lymphoma Treatment Market Overview

1.1 Non Hodgkin Lymphoma Treatment Product Overview

1.2 Non Hodgkin Lymphoma Treatment Market Segment by Type

1.3 Global Non Hodgkin Lymphoma Treatment Market Size by Type (2015-2027)

1.3.1 Global Non Hodgkin Lymphoma Treatment Market Size Overview by Type (2015-2027)

1.3.2 Global Non Hodgkin Lymphoma Treatment Historic Market Size Review by Type (2015-2021)

1.3.2.1 Global Non Hodgkin Lymphoma Treatment Sales Market Share Breakdown by Type (2015-2027)

1.3.2.2 Global Non Hodgkin Lymphoma Treatment Market Share Breakdown by Type (2015-2027)

1.3.2.3 Global Non Hodgkin Lymphoma Treatment Average Selling Price (ASP) by Type (2015-2027)

1.3.3 Global Non Hodgkin Lymphoma Treatment Market Size Forecast by Type (2021-2027)

1.3.3.1 Global Non Hodgkin Lymphoma Treatment Sales Market Share Breakdown by Application (2021-2027)

1.3.3.2 Global Non Hodgkin Lymphoma Treatment Revenue Market Share Breakdown by Application (2021-2027)

1.3.3.3 Global Non Hodgkin Lymphoma Treatment Average Selling Price (ASP) by Application (2021-2027)

1.4 Key Regions Market Size Segment by Type (2015-2021)

1.4.1 North America Non Hodgkin Lymphoma Treatment Sales Breakdown by Type (2015-2027)

1.4.2 Europe Non Hodgkin Lymphoma Treatment Sales Breakdown by Type (2015-2027)

1.4.3 Asia-Pacific Non Hodgkin Lymphoma Treatment Sales Breakdown by Type (2015-2027)

1.4.4 Latin America Non Hodgkin Lymphoma Treatment Sales Breakdown by Type (2015-2027)

1.4.5 Middle East and Africa Non Hodgkin Lymphoma Treatment Sales Breakdown by Type (2015-2027)

2 Global Non Hodgkin Lymphoma Treatment Market Competition by Company

2.1 Global Top Players by Non Hodgkin Lymphoma Treatment Sales (2015-2021)

2.2 Global Top Players by Non Hodgkin Lymphoma Treatment Revenue (2015-2021)

2.3 Global Top Players Non Hodgkin Lymphoma Treatment Average Selling Price (ASP) (2015-2021)

2.4 Global Top Company Non Hodgkin Lymphoma Treatment Manufacturing Base Distribution, Sales Area, Product Type

2.5 Non Hodgkin Lymphoma Treatment Market Competitive Situation and Trends

2.5.1 Non Hodgkin Lymphoma Treatment Market Growth Rate (2015-2021)

2.5.2 Global 5 and 10 Largest Company by Non Hodgkin Lymphoma Treatment Sales and Revenue in 2019

2.6 Global Top Company by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non Hodgkin Lymphoma Treatment as of 2019)

2.7 Date of Key Company Enter into Non Hodgkin Lymphoma Treatment Market

2.8 Key Company Non Hodgkin Lymphoma Treatment Product Offered

2.9 Mergers and Acquisitions, Expansion

3 Global Non Hodgkin Lymphoma Treatment Status and Outlook by Region (2015-2027)

3.1 Global Non Hodgkin Lymphoma Treatment Market Size and CAGR by Region: 2015 VS 2021 VS 2027

3.2 Global Non Hodgkin Lymphoma Treatment Market Size Market Share by Region (2015-2021)

3.2.1 Global Non Hodgkin Lymphoma Treatment Sales Market Share by Region (2015-2021)

3.2.2 Global Non Hodgkin Lymphoma Treatment Revenue Market Share by Region (2015-2021)

3.2.3 Global Non Hodgkin Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2015-2021)

3.3 Global Non Hodgkin Lymphoma Treatment Market Size Market Share by Region (2021-2027)

3.3.1 Global Non Hodgkin Lymphoma Treatment Sales Market Share by Region (2021-2027)

3.3.2 Global Non Hodgkin Lymphoma Treatment Revenue Market Share by Region (2021-2027)

3.3.3 Global Non Hodgkin Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2021-2027)

3.4 North America Non Hodgkin Lymphoma Treatment Market Size By Growth (2015-2027)

3.4.1 North America Non Hodgkin Lymphoma Treatment Revenue By Growth (2015-2027)

3.4.2 North America Non Hodgkin Lymphoma Treatment Sales By Growth (2015-2027)

3.5 Asia-Pacific Non Hodgkin Lymphoma Treatment Market Size By Growth (2015-2027)

TOC Continued….

Report Focus:

  • Extensive product offerings
  • Customer research services
  • Robust research methodology
  • Comprehensive reports
  • Latest technological developments
  • Value chain analysis
  • Potential Non Hodgkin Lymphoma Treatment Market opportunities
  • Growth dynamics
  • Quality assurance
  • Post-sales support
  • Regular report updates

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

Sign up and submit a press release

Sponsored
Ark Surgical Performs First Hysterectomies in the USA with its FDA-Cleared LapBox for Manual Morcellation

Ark Surgical Performs First Hysterectomies in the USA with its FDA-Cleared LapBox for Manual Morcellation

PACKAGING COMPLIANCE LABS WELCOMES NEW CFO, BERNADETTE LEGARETTA

PACKAGING COMPLIANCE LABS WELCOMES JENN GOFF, VP SALES, MARKETING, AND INNOVATION

Clarius Debuts its First Dual-Array Wireless Handheld Scanner Enabling Whole-Body Views of Superficial to Deep Anatomy

Clarius Debuts its First Dual-Array Wireless Handheld Scanner Enabling Whole-Body Views of Superficial to Deep Anatomy

National Liver Health Awareness Month Highlights the Urgent Need for Liver Disease Prevention

National Liver Health Awareness Month Highlights the Urgent Need for Liver Disease Prevention

interviews & reviews
A Wearable to Manage Parkinson’s Motor Symptoms: Interview with Lucy Jung, CEO at Charco Neurotech

A Wearable to Manage Parkinson’s Motor Symptoms: Interview with Lucy Jung, CEO at Charco Neurotech

Eko’s Newest CORE 500 Stethoscope: A Review

Eko’s Newest CORE 500 Stethoscope: A Review

Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!